Blood News and Research

RSS

Synovis Life Technologies' Flow Coupler receives FDA marketing approval

Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company’s well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.

9 Feb 2010

Inovio Biomedical announces additional immunogenicity data from therapeutic cervical cancer vaccine trial

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today additional interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial. VGX-3100 is a DNA vaccine targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16 and 18 and is delivered via in vivo electroporation.

8 Feb 2010

Cord Blood America finalizes agreement to process and store cord blood specimens for BioCells

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has finalized an agreement to process and store cord blood specimens for BioCells, Inc., headquartered in Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico.

8 Feb 2010

Researchers find low prevalence of tamoxifen use for prevention of breast cancer among women

Researchers with the National Cancer Institute (NCI) have found that the prevalence of tamoxifen use for the prevention of breast cancer among women without a personal history of breast cancer is very low.

8 Feb 2010

Investigational drug for osteoporosis inhibits serotonin synthesis in the gut

An investigational drug that inhibits serotonin synthesis in the gut, administered orally once daily, effectively cured osteoporosis in mice and rats reports an international team led by researchers from Columbia University Medical Center, in the Feb. 7 issue of Nature Medicine.

7 Feb 2010

Risk of heart attack greater in women with gout

Women with gout are at greater risk of a heart attack than men with the disease, indicates research published ahead of print in the Annals of the Rheumatic Diseases.

7 Feb 2010

HealthSpring nurse practitioner identifies impending heart attack

Olive Branch, Miss. resident Glenn Lusk has a special perspective on the value of his Medicare Advantage plan. It was a HealthSpring-contracted nurse practitioner who discovered during a home visit in November that Lusk was experiencing serious heart trouble.

6 Feb 2010

Athlete hopes for first U.S. cross-country medal; health issues plagued 2006 Olympic bid

Kris Freeman is back in the hunt for an Olympic medal in Vancouver after being named today to the U.S. ski team following a disappointing finish at the 2006 Games in Torino, Italy.

6 Feb 2010

Artificial pancreas can help manage diabetes in kids overnight

In a landmark study in children and teenagers with type 1 diabetes, JDRF-funded researchers at the University of Cambridge showed that using a first-generation artificial pancreas system overnight can lower the risk of low blood sugar emergencies while sleeping, and at the same time improve diabetes control.

6 Feb 2010

Two U.S. insurers approve coverage of radioembolization for treatment of unresectable liver cancer

MDS Nordion, a global leader in providing products and services for medical imaging and radiotherapeutics, today announced that two of the largest health insurers in the United States have recently approved coverage of radioembolization to treat unresectable liver cancer, which includes the use of MDS Nordion's TheraSphere(R) treatment. The two insurance companies and their affiliates together serve more than one-quarter of Americans and do business in all 50 states.

6 Feb 2010

HDC partners with New York surgery center to develop new molecular diagnostic tests for pancreatic cancer

Health Discovery Corporation announced today that the Company has entered into an exclusive agreement with the Pancreas, Biliary and Liver Surgery Center of New York at Saint Vincent Catholic Medical Centers in New York City to develop new molecular diagnostic tests for the early detection of pancreatic cancer. The Pancreas, Biliary and Liver Surgery Center is under the leadership of Drs. Michael Wayne, Franklin Kassim and Avram Cooperman.

6 Feb 2010

Cardiologists recommend tips to prevent heart disease

There's a lot you can do to reduce your risk of heart disease and improve your chances for a longer, healthier life. Cardiologists from The Polyclinic in Seattle recommend that you first, learn more about some of the risk factors for heart disease.

6 Feb 2010

FDA grants Talecris Biotherapeutics orphan drug designation for Alpha1-Proteinase Inhibitor to treat AAT deficiency

Talecris Biotherapeutics, Inc. announced today that it was granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the development of an aerosol formulation of Alpha1-Proteinase Inhibitor (Human, A1PI) to treat congenital alpha1-antitrypsin (AAT) deficiency. AAT deficiency is a chronic, hereditary condition that increases the risk of certain diseases, especially emphysema, which typically emerges in the fourth decade of life. Currently, there are no approved, inhaled treatments available for the treatment of AAT deficiency.

5 Feb 2010

EBMT honours abstract on Defibrotide in Hepatic VOD prevention with the Van Bekkum Award

Gentium S.p.A. today announced that the abstract titled, "Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/III multicentre study," has been awarded the Van Bekkum Award for the best abstract submitted to the physician's program for the European Group for Blood and Marrow Transplantation's (EBMT) 36th Annual Meeting, to be held in Vienna, March 21-24, 2010.

5 Feb 2010

BioTime announces results of independent Hextend study in hemodynamically unstable trauma patients

BioTime, Inc. today reported recently-released results from an independent study evaluating the use of Hextend® in hemodynamically unstable trauma patients. Hextend (6% Hetastarch in Lactated Electrolyte Injection) is BioTime’s commercially-available blood plasma volume expander used to treat hypovolemia (low blood volume). The study, conducted at the University of Miami Ryder Trauma Center, reported that initial resuscitation with Hextend was associated with no obvious coagulopathy and reduced mortality compared to fluid resuscitation without Hextend.

5 Feb 2010

News piece may highlight the importance of cord blood donation among Hispanic and Latino community

CORD:USE Cord Blood Bank and its program at South Miami Hospital are being featured on CNN en Espanol's show "Salud." This story on the importance of cord blood donation aired this week and can be seen Friday, February 5 at 9:30 a.m. EST and Sunday, February 7 at 9 a.m. EST and 3 p.m. EST on CNN en Espanol.

5 Feb 2010

AFGE provides solutions to tackle VA claims backlog

John McCray, a Rating Veterans Service Representative (RVSR) at the Veterans Benefits Administration, (VBA) in the Los Angeles Regional Office, testified on behalf of the American Federation of Government Employees (AFGE) at a hearing held before the House of Representatives Committee on Veterans' Affairs. The hearing was aimed at updating Congress on the implementation on the Veterans' Benefits Improvement Act, P.L. 110-389.

5 Feb 2010

Safety checklist reduces bloodstream infections in ICUs

The state of Michigan, which used a five-step checklist developed at Johns Hopkins to virtually eliminate bloodstream infections in its hospitals' intensive care units , has been able to keep the number of these common, costly and potentially lethal infections near zero - even three years after first adopting the standardized procedures.

5 Feb 2010

Tracking early signs of coronary artery clogs: CT perfusion vs. SPECT nuclear imaging tests

Cardiologists and heart imaging specialists at 15 medical centers in eight countries, and led by researchers at Johns Hopkins, have enrolled the first dozen patients in a year-long investigation to learn whether the subtle squeezing of blood flow through the inner layers of the heart is better than traditional SPECT nuclear imaging tests and other diagnostic radiology procedures for accurately tracking the earliest signs of coronary artery clogs.

5 Feb 2010

EVMS researchers identify source that causes Type 1 diabetes

Doctors at Eastern Virginia Medical School's Strelitz Diabetes Center have been stalking the culprit responsible for Type 1 diabetes. Now, they are one step closer.

5 Feb 2010

Blood News and Research

Synovis Life Technologies' Flow Coupler receives FDA marketing approval

Inovio Biomedical announces additional immunogenicity data from therapeutic cervical cancer vaccine trial

Cord Blood America finalizes agreement to process and store cord blood specimens for BioCells

Researchers find low prevalence of tamoxifen use for prevention of breast cancer among women

Investigational drug for osteoporosis inhibits serotonin synthesis in the gut

Risk of heart attack greater in women with gout

HealthSpring nurse practitioner identifies impending heart attack

Athlete hopes for first U.S. cross-country medal; health issues plagued 2006 Olympic bid

Artificial pancreas can help manage diabetes in kids overnight

Two U.S. insurers approve coverage of radioembolization for treatment of unresectable liver cancer

HDC partners with New York surgery center to develop new molecular diagnostic tests for pancreatic cancer

Cardiologists recommend tips to prevent heart disease

FDA grants Talecris Biotherapeutics orphan drug designation for Alpha1-Proteinase Inhibitor to treat AAT deficiency

EBMT honours abstract on Defibrotide in Hepatic VOD prevention with the Van Bekkum Award

BioTime announces results of independent Hextend study in hemodynamically unstable trauma patients

News piece may highlight the importance of cord blood donation among Hispanic and Latino community

AFGE provides solutions to tackle VA claims backlog

Safety checklist reduces bloodstream infections in ICUs

Tracking early signs of coronary artery clogs: CT perfusion vs. SPECT nuclear imaging tests

EVMS researchers identify source that causes Type 1 diabetes

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News